in Treating Children Acute Upper Respiratory Tract Infection with Heat Syndrome of Both Exterior and Interior

LI Meifang; HU Siyuan; LI Xinmin; WU Ge; JIANG Jinjin; FENG Ziwei; HAN Xuanming; ZHANGYamei; JIA Yanhong; HONG Lijun; LI Weiwei; DU Yonggang; TIAN Weizheng; DONG Caiqin; LUO Hongfang; GAO Moli; MA Qingping; LI Lei

doi:10.13288/j.11-2166/r.2020.18.013

您当前的位置：

首页 >

文章列表页 >

in Treating Children Acute Upper Respiratory Tract Infection with Heat Syndrome of Both Exterior and Interior

更新时间：2021-11-10

- in Treating Children Acute Upper Respiratory Tract Infection with Heat Syndrome of Both Exterior and Interior
- Journal of Traditional Chinese Medicine Vol. 61, Issue 18, Pages: 1617-1622(2020)
- 作者机构：
  
  1. 天津中医药大学第一附属医院
  2. 山西省运城市妇幼保健院
  3. 上海长海医院
  4. 贵州医科大学第二附属医院
  5. 河南省漯河市中医院
  6. 河北省迁安市中医医院
  7. 陕西中医药大学第二附属医院
  8. 河北工程大学附属医院
  9. 黑龙江省佳木斯市中医院
  10. 中国中药协会药物研究评价技术中心
  11. 山西省汾阳医院
  12. 黑龙江省牡丹江市中医医院
  13. 黑龙江省哈尔滨市中医医院
  14. 山西省长治市人民医院
  15. 四川省眉山市中医医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2020.18.013
  CLC： R272
- Published：2020
- 稿件说明：
移动端阅览
[1]李梅芳,胡思源,李新民,伍戈,蒋瑾瑾,冯自威,韩选明,张雅梅,贾艳红,洪丽军,李微微,杜永刚,田维政,董彩琴,罗红芳,高茉丽,马清平,李磊.小儿热速清糖浆治疗小儿急性上呼吸道感染表里俱热证随机对照多中心研究[J].中医杂志,2020,61(18):1617-1622.

LI Meifang, HU Siyuan, LI Xinmin, et al. in Treating Children Acute Upper Respiratory Tract Infection with Heat Syndrome of Both Exterior and Interior[J]. Journal of Traditional Chinese Medicine2020, 61(18): 1617-1622.
[1]李梅芳,胡思源,李新民,伍戈,蒋瑾瑾,冯自威,韩选明,张雅梅,贾艳红,洪丽军,李微微,杜永刚,田维政,董彩琴,罗红芳,高茉丽,马清平,李磊.小儿热速清糖浆治疗小儿急性上呼吸道感染表里俱热证随机对照多中心研究[J].中医杂志,2020,61(18):1617-1622. DOI： 10.13288/j.11-2166/r.2020.18.013.

LI Meifang, HU Siyuan, LI Xinmin, et al. in Treating Children Acute Upper Respiratory Tract Infection with Heat Syndrome of Both Exterior and Interior[J]. Journal of Traditional Chinese Medicine2020, 61(18): 1617-1622. DOI： 10.13288/j.11-2166/r.2020.18.013.

摘要

目的评价小儿热速清糖浆治疗小儿急性上呼吸道感染表里俱热证的有效性及安全性。方法采用区组随机、双盲双模拟、阳性药对照、多中心的临床研究方法。计划纳入480例

其中治疗组360例服用小儿热速清糖浆与小儿清热宁颗粒模拟剂

对照组120例服用小儿清热宁颗粒与小儿热速清糖浆模拟剂

两组疗程均为5天。比较两组完全退热时间、便秘疗效、中医证候疗效、单项症状消失率、即时退热时间与退热持续时间

安全性指标。结果共纳入468例

其中治疗组352例

对照组116例。全分析数据集（FAS）结果显示

治疗后治疗组与对照组的完全退热中位时间均为48h

经COX回归模型估计组间风险比（HR）及95%可信区间

在校正中心因素的影响后

按0.67的非劣标准

治疗组非劣效于对照组。治疗后治疗组、对照组便秘总有效率分别为96.54%、88.70%

组间比较差异均有统计学意义（P<0.05）;治疗组、对照组中医证候痊愈率分别为46.40%、31.30%（P<0.05）。本研究共发现7例不良事件

治疗组4例（1.15%）

对照组3例（2.59%）。结论小儿热速清糖浆治疗小儿急性上呼吸道感染表里俱热证具有缩短热程作用

疗效不劣于小儿清热宁颗粒

且两药的安全性均良好。

Abstract

Objective To evaluate the effectiveness and safety of Xiaoer Resuqing Syrup（小儿热速清糖浆） in the treatment of children acute upper respiratory tract infection with heat syndrome of both exterior and interior. Method Block randomization

double blind double simulation

positive drug control

multi-center clinical research methods were used. It is planned to enroll 480 cases

including 360 cases in the treatment group and 120 cases in the control group. The treatment group was treated with Xiaoer Resuqing Syrup and Xiaoer Qingrening Granule（小儿清热宁颗粒） simulator

while the control group was treated with Xiaoer Qingrening Granules and Xiaoer Resuqing Syrup simulator. The course of treatment was 5 days. The time to complete antipyretics

the efficacy of constipation

the efficacy of traditional Chinese medicine（TCM） syndromes

the disappearance rate of single symptoms

the instantaneous antipyretic time and the duration of antipyretics

safety indicators were compared between the 2 groups. Results A total of 468 cases were included

including 352 cases in the treatment group and 116 cases in the control group. The results of the full analysis data set（FAS） showed that the median time to complete fever in the two groups were both 48 hours. The risk ratio（HR） and 95% confidence interval between the groups were estimated by the COX regression model. After adjusting the influence of central factors

according to the non-inferiority standard of 0.67

the treatment group was non-inferior to the control group. After treatment

the total effective rate of constipation in the treatment group and the control group was 96.54% and 88.70%

respectively. The differences between groups were statistically significant（P<0.05）; the curative rate of TCM syndromes in the treatment group and the control group were respectively 46.40%

and 31.30%（P<0.05）. A total of 7 cases of adverse events were found in this study including 4 cases（1.15%） in the treatment group and 3 cases（2.59%） in the control group. Conclusion Xiao′er Resuqing Syrup has the effect of shortening the heat course in the treatment of children acute upper respiratory tract infection with heat syndrome of both exterior and interior. The curative effect is not inferior to that of Xiaoer Qingrening Granules

and both drugs were of good safety.

关键词

Keywords

references

查看原文

Views

172

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Methodological Issues in the Design，Evaluation，and Reporting of Randomized Controlled Trials with "Pattern Dominating Disease"

Effect of Electroacupuncture on Metabolism-Inflammation Network in Patients with Simple Obesity：A Randomized Controlled Trial

Acupuncture Treatment for Severe Bell's Palsy and Its Impact on Serum GDNF and NGF：A Randomized Controlled Trial

Effect of Heat-sensitive Moxibustion on Quality of Life and Immune Function in Non-Small Cell Lung Cancer Patients with Qi Deficiency and Phlegm Stasis Syndrome Undergoing Chemotherapy：A Randomized Controlled Trial

Professor WU Rongzu's Clinical Experience in Treating Irritable Bowel Syndrome with Constipation Using Fuyang Tongmi Decoction （扶阳通秘汤）

Related Author

WANG Lu

WANG Jiajia

ZHANG Yingying

LUO Xufei

CHEN Yaolong

LI Jiansheng

SHU Qi

PENG Qiumei

Related Institution

Lung Disease Diagnosis and Treatment，The First Affiliated Hospital of Henan University of Chinese Medicine

Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-constructed by Henan Province Education Ministry of P.R.China/Henan Key Laboratory of Chinese Medicine for Respiratory Diseases，Henan University of Chinese Medicine

School of Chinese Medicine，Hong Kong Baptist University

Research Unit of Evidence-Based Evaluation and Guidelines，Chinese Academy of Medical Sciences，School of Basic Medical Sciences，Lanzhou University

Key Laboratory of Evidence Based Medicine of Gansu Province

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰